These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 10700027

  • 1. Enhanced cerebral uptake of receptor ligands by modulation of P-glycoprotein function in the blood-brain barrier.
    Doze P, Van Waarde A, Elsinga PH, Hendrikse NH, Vaalburg W.
    Synapse; 2000 Apr; 36(1):66-74. PubMed ID: 10700027
    [Abstract] [Full Text] [Related]

  • 2. Positron emission tomography studies on binding of central nervous system drugs and P-glycoprotein function in the rodent brain.
    Elsinga PH, Hendrikse NH, Bart J, van Waarde A, Vaalburg W.
    Mol Imaging Biol; 2005 Apr; 7(1):37-44. PubMed ID: 15912274
    [Abstract] [Full Text] [Related]

  • 3. P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan.
    de Vries NA, Zhao J, Kroon E, Buckle T, Beijnen JH, van Tellingen O.
    Clin Cancer Res; 2007 Nov 01; 13(21):6440-9. PubMed ID: 17975156
    [Abstract] [Full Text] [Related]

  • 4. Kinetic analysis of the cooperation of P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone.
    Kodaira H, Kusuhara H, Ushiki J, Fuse E, Sugiyama Y.
    J Pharmacol Exp Ther; 2010 Jun 01; 333(3):788-96. PubMed ID: 20304939
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and Preclinical Evaluation of Three Novel Fluorine-18 Labeled Radiopharmaceuticals for P-Glycoprotein PET Imaging at the Blood-Brain Barrier.
    Savolainen H, Cantore M, Colabufo NA, Elsinga PH, Windhorst AD, Luurtsema G.
    Mol Pharm; 2015 Jul 06; 12(7):2265-75. PubMed ID: 26043236
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium.
    Swed A, Eyal S, Madar I, Zohar-Kontante H, Weiss L, Hoffman A.
    Mol Pharm; 2009 Jul 06; 6(6):1883-90. PubMed ID: 19722701
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of a P-glycoprotein inhibitor, Cyclosporin A, on the disposition in rodent brain and blood of the 5-HT1A receptor radioligand, [11C](R)-(-)-RWAY.
    Liow JS, Lu S, McCarron JA, Hong J, Musachio JL, Pike VW, Innis RB, Zoghbi SS.
    Synapse; 2007 Feb 06; 61(2):96-105. PubMed ID: 17117422
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis and Evaluation of New Fluorine-18 Labeled Verapamil Analogs To Investigate the Function of P-Glycoprotein in the Blood-Brain Barrier.
    Raaphorst RM, Luurtsema G, Schuit RC, Kooijman EJM, Elsinga PH, Lammertsma AA, Windhorst AD.
    ACS Chem Neurosci; 2017 Sep 20; 8(9):1925-1936. PubMed ID: 28650628
    [Abstract] [Full Text] [Related]

  • 18. Assessing the Impact of Lithium Chloride on the Expression of P-Glycoprotein at the Blood-Brain Barrier.
    Newman SA, Pan Y, Short JL, Nicolazzo JA.
    J Pharm Sci; 2017 Sep 20; 106(9):2625-2631. PubMed ID: 28093288
    [Abstract] [Full Text] [Related]

  • 19. P-glycoprotein-mediated active efflux of the anti-HIV1 nucleoside abacavir limits cellular accumulation and brain distribution.
    Shaik N, Giri N, Pan G, Elmquist WF.
    Drug Metab Dispos; 2007 Nov 20; 35(11):2076-85. PubMed ID: 17709369
    [Abstract] [Full Text] [Related]

  • 20. Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption.
    Uhr M, Steckler T, Yassouridis A, Holsboer F.
    Neuropsychopharmacology; 2000 Apr 20; 22(4):380-7. PubMed ID: 10700657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.